论文部分内容阅读
异常脂蛋白血症是冠心病的独立危险因素,长期治疗异常脂蛋白血症对防治冠心病有重要意义。作者用 Tyquanol 长期治疗冠心病伴发异常脂蛋白血症并取得了满意而显著的疗效。现报告如下。对象与方法共选择33例冠心病伴发异常脂蛋白血症患者为研究对象。男11例,女22例;年龄:50岁以下10例,51～60岁13例,61～70岁10例。33例患者中全部患Ⅱ～Ⅲ级稳定型劳累性心绞痛,16例患过心肌梗死,23例伴发高血
Abnormal lipoproteinemia is an independent risk factor for coronary heart disease, long-term treatment of dyslipoproteinemia prevention and treatment of coronary heart disease is of great significance. The authors used Tyquanol long-term treatment of coronary heart disease associated with dyslipoproteinemia and achieved satisfactory and significant effect. The report is as follows. Subjects and Methods A total of 33 patients with coronary heart disease and dyslipoproteinemia were selected as the study subjects. There were 11 males and 22 females. Ages: 10 under 50 years old, 13 cases 51 to 60 years old and 10 cases 61 to 70 years old. All 33 patients had stable angina pectoris Ⅱ ~ Ⅲ, 16 patients had myocardial infarction, 23 patients with high blood